Debiopharm develops, manufactures, and invests in innovative therapies and technologies that respond to high unmet medical needs in oncology and bacterial infections. In addition to drug development and manufacturing, Debiopharm aims to provide strategic funding and guidance for companies with an ambition to improve the patient journey and re-imagine how clinical trials are conducted. Since 2018 Debiopharm has invested over USD 120 million, typically leading the investment rounds of its 16 portfolio companies. Its growing portfolio company achievements include 10 FDA clearances, 13 CE marks, 2 IPOs, and 5 trade exits.
Everything we do is for the benefit of patients and their quality of life. Join us to help make their lives better.
At Debiopharm, we don’t just develop medicines, we strive to offer patients complete health solutions from diagnostics to treatment and treatment monitoring. Diversity, passion and commitment are the driving forces behind Debiopharm’s employees. With us you will have a unique opportunity to develop and broaden your skills.
Health and safety are important to us and we offer different preventive healthcare programs, conferences and workshops throughout the year.
Willing to discover more and join us? We are a globally active group and we strive to recruit highly competent, agile and committed professionals for each opportunity. Available positions are regularly listed on our website. Should there be no current opening, send us a spontaneous job application.
Benefits:
- Transports
- Parking
- Repas
Company Restaurant - Retraite
- Fruits et paniers
- Work from home
- Boissons
Eckdaten
- 251 - 500 Mitarbeitende
- Chemin Messidor 5-7, 1002 Lausanne
- Debiopharm Research & Manufacturing SA
Neue Stellenangebote direkt in deiner Mailbox?
Derzeit sind keine Stellenangebote vorhanden. Folge diesem Unternehmen, und wir informieren dich, sobald neue Stellen verfügbar sind.